HERON THERAPEUTICS INC (HRTX)
US4277461020 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 20.45M | 28.68M | 15.40M | 90.50M | 105.10M | |||
| Marketable Securities | 51.07M | 51.73M | 69.50M | 67.00M | 103.40M | |||
| Receivables | 65.32M | 60.14M | 52.00M | 35.50M | 41.90M | |||
| Inventories | 42.47M | 42.11M | 54.60M | 48.40M | 41.90M | |||
| Other Current Assets | 6.58M | 6.12M | 14.00M | 13.00M | 22.00M | |||
| Total Current Assets | 185.90M | 188.77M | 205.40M | 254.40M | 314.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.10M | 25.60M | 29.80M | 33.60M | 39.00M | |||
| Other Non-Current Assets | 7.88M | 8.13M | 15.70M | 17.70M | 300.00K | |||
| Total Non-Current Assets | 31.98M | 33.73M | 45.60M | 51.30M | 39.40M | |||
| TOTAL ASSETS | 217.89M | 222.51M | 251.00M | 305.70M | 353.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 7.10M | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 74.54M | 75.47M | 78.10M | 66.60M | 94.60M | |||
| Accounts Payable | 837.00K | 3.24M | 3.20M | 3.80M | 500.00K | |||
| Other Current Liabilities | N/A | 974.00K | 1.00M | 600.00K | 300.00K | |||
| Total Current Liabilities | 75.38M | 79.69M | 82.40M | 71.10M | 102.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 149.54M | 149.49M | 149.30M | 149.10M | 0.00 | |||
| Other Non-Current Liabilities | 26.73M | 27.30M | 5.70M | 8.00M | 14.60M | |||
| Total Non-Current Liabilities | 176.28M | 176.79M | 155.00M | 157.00M | 14.60M | |||
| TOTAL LIABILITIES | 251.65M | 256.48M | 237.40M | 228.10M | 117.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.91B | -1.91B | -1.80B | -1.61B | -1.39B | |||
| Additional Paid In Capital | 1.87B | 1.87B | 1.81B | 1.69B | 1.63B | |||
| Common Shares | 1.50M | 1.50M | 1.20M | 1.00M | 900.00K | |||
| Other Shareholders' Equity | -6.00K | 13.00K | 0.00 | 0.00 | 300.00K | |||
| Shares Outstanding | 150.38M | 150.29M | 119.20M | 102.00M | 91.30M | |||
| Tangible Book Value per Share | -0.22 | -0.23 | 0.11 | 0.76 | 2.59 | |||
| Total Shareholders' Equity | -33.77M | -33.97M | 13.60M | 77.60M | 236.50M | |||
| TOTAL LIABILITIES AND EQUITY | 217.89M | 222.51M | 251.00M | 305.70M | 353.60M | |||
| Statistics | ||||||||
| Debt/Equity | -4.43 | -4.40 | 10.98 | 1.92 | N/A | |||
| Current Ratio | 2.47 | 2.37 | 2.49 | 3.58 | 3.07 | |||
| Return On Assets (ROA) | -37.15% | -49.69% | -72.51% | -72.19% | -64.28% | |||
| Return On Equity (ROE) | N/A | N/A | -1338.24% | -284.41% | -96.11% | |||
All data in USD